Compound K attenuates glucose intolerance and hepatic steatosis through AMPK-dependent pathways in type 2 diabetic OLETF rats
Yoo-Cheol Hwang, Da-Hee Oh, Moon Chan Choi, Sang Yeoul Lee, Kyu-Jeong Ahn, Ho-Yeon Chung, Sung-Jig Lim, Sung Hyun Chung, In-Kyung Jeong
Korean J Intern Med. 2018;33(2):347-355.   Published online 2017 Feb 1     DOI: https://doi.org/10.3904/kjim.2015.208
Citations to this article as recorded by Crossref logo
Ginsenoside compound K alleviates sodium valproate-induced hepatotoxicity in rats via antioxidant effect, regulation of peroxisome pathway and iron homeostasis
Luping Zhou, Lulu Chen, Xiangchang Zeng, Jianwei Liao, Dongsheng Ouyang
Toxicology and Applied Pharmacology.2020; 386: 114829.     CrossRef
Improving hepatic mitochondrial biogenesis as a postulated mechanism for the antidiabetic effect of Spirulina platensis in comparison with metformin
Ghaleb A. Oriquat, Mennatallah A. Ali, Shimaa A. Mahmoud, Rania M.H.M. Eid, Rania Hassan, Maher A. Kamel
Applied Physiology, Nutrition, and Metabolism.2019; 44(4): 357.     CrossRef
Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes
Litao Bai, Jialiang Gao, Fan Wei, Jing Zhao, Danwei Wang, Junping Wei
Frontiers in Pharmacology.2018;[Epub]     CrossRef
Protective effect of triterpenes against diabetes-induced β-cell damage: An overview of in vitro and in vivo studies
Sihle E. Mabhida, Phiwayinkosi V. Dludla, Rabia Johnson, Musawenkosi Ndlovu, Johan Louw, Andy R. Opoku, Rebamang A. Mosa
Pharmacological Research.2018; 137: 179.     CrossRef
New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the “Bacteria-Mucosal Immunity-Inflammation-Diabetes” Axis
Zezheng Gao, Qingwei Li, Xuemin Wu, Xuemin Zhao, Linhua Zhao, Xiaolin Tong
Journal of Immunology Research.2017; 2017: 1.     CrossRef